Brice C.
- Country
- France
- Department
- Medical Oncology
Research Overview
- Evaluation of AMG 193 Combined with Additional Therapies in Advanced Gastrointestinal, Biliary Tract, or Pancreatic Cancers with Homozygous MTAP-Deletion
- Evaluation of Molecular Targeted Maintenance Therapy with Binimetinib, Futibatinib, and Drug Combination in Advanced Biliary Cancer: A Phase 3 Randomized Trial
- Phase III Randomized Double-Blind Study of Rilvegostomig Plus Chemotherapy in Adjuvant Treatment of Resected Biliary Tract Adenocarcinoma
Data & Insights
Has run more than one trial at 81 of 195 partner sites.
Specializations
Biliary Tract Cancer Expertise
The investigator specializes in treating advanced biliary tract cancer (BTC) and its various manifestations, including intrahepatic and extrahepatic cholangiocarcinoma.
- Advanced Biliary Cancer (ABC) Management
- Gallbladder Cancer Treatment
- Post-surgical Therapeutic Approaches
Their clinical focus extends to both metastatic disease and localized cases requiring surgical intervention.
Precision Medicine Applications
The investigator applies personalized medicine approaches in treating biliary tract malignancies, with particular attention to molecular targeted therapies and biomarker-driven treatment selection.
- Targeted Therapeutic Strategies
- Molecular Profiling Integration
- MTAP-deletion Assessment
Their work encompasses innovative therapeutic combinations tailored to specific genetic profiles.
Gastrointestinal Oncology
The investigator's expertise extends to broader gastrointestinal tract malignancies, with specialized focus on cancers affecting the biliary system and pancreas.
- Combined Modality Treatment
- Novel Therapeutic Agents
- Maintenance Treatment Strategies
Their practice integrates both standard chemotherapy protocols and emerging therapeutic approaches.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.